title: Targeting precision medicine toxicity: recent developments.
authors: Sage Publications Ltd, 1 Oliver's Yard, 55 City Road, London, EC1Y 1SP, London, UK.
authors: Gordon
authors: G
authors: Mallarkey
authors: Department of Clinical Pharmacology, School of Medicine, Flinders University and Flinders Medical Centre, Bedford Park, SA 5042, Australia.
authors: Arduino A
authors: AA
authors: Mangoni
references: Clin Ther. 2009 Nov;31(11):2549-58
references: 20109999
references: J Clin Oncol. 2009 Mar 1;27(7):1075-81
references: 19139427
references: J Clin Oncol. 2008 Dec 20;26(36):5950-6
references: 19018089
references: Int J Clin Oncol. 2012 Dec;17 (6):542-50
references: 23138271
references: Lancet Oncol. 2014 Sep;15(10):e447-60
references: 25186048
references: Blood. 2014 Oct 9;124(15):2467-8
references: 25301337
references: Oncologist. 2014 Apr;19(4):344-5
references: 24674875
references: J Clin Oncol. 2010 Jul 1;28(19):3167-75
references: 20516446
references: N Engl J Med. 2012 Jun 28;366(26):2443-54
references: 22658127
references: Ann Oncol. 2005 Apr;16(4):549-57
references: 15695501
references: Ann Oncol. 2012 Oct;23 Suppl 7:vii155-66
references: 22997448
references: J Clin Oncol. 2011 May 20;29(15):2011-9
references: 21502544
references: J Clin Endocrinol Metab. 2014 Nov;99(11):4078-85
references: 25078147
references: Am J Clin Oncol. 2015 Oct;38(5):442-7
references: 23934135
references: Br J Dermatol. 2009 Sep;161(3):515-21
references: 19466958
references: J Clin Oncol. 2007 May 1;25(13):1670-6
references: 17470860
references: Oncologist. 2001;6(1):81-91
references: 11161231
references: J Clin Oncol. 2013 Jun 10;31(17 ):e283-7
references: 23650406
references: Circulation. 2012 May 1;125(17):2128-37
references: 22451584
references: J Clin Oncol. 2012 May 20;30(15):1755-62
references: 22473155
references: Aliment Pharmacol Ther. 2013 Oct;38(7):674-88
references: 23957651
references: N Engl J Med. 2013 Jul 11;369(2):134-44
references: 23724846
references: Gut. 2012 Feb;61(2):179-92
references: 22057051
references: N Engl J Med. 2011 Jun 30;364(26):2507-16
references: 21639808
references: Clin Pharmacol Ther. 2010 Feb;87(2):197-203
references: 19924121
references: Cancer Immunol Res. 2013 Aug;1(2):85-91
references: 24777499
references: Lancet. 2012 Jul 28;380(9839):358-65
references: 22735384
references: F1000Prime Rep. 2013 Apr 02;5:11
references: 23585929
references: J Clin Oncol. 2005 Dec 10;23(35):8968-77
references: 16204013
references: J Clin Oncol. 2007 Aug 1;25(22):3362-71
references: 17664484
references: Aliment Pharmacol Ther. 2007 Aug 15;26(4):555-63
references: 17661759
references: Can J Cardiol. 2014 May;30(5):534-43
references: 24786444
references: J Clin Oncol. 2002 Jun 15;20(12):2812-23
references: 12065558
references: J Clin Oncol. 2007 Oct 20;25(30):4779-86
references: 17947725
references: Nat Rev Cancer. 2007 May;7(5):332-44
references: 17457301
references: Target Oncol. 2014 Sep;9(3):195-204
references: 23852656
references: N Engl J Med. 2012 Nov;367 (18):1694-703
references: 23020132
references: Lung Cancer. 2012 Aug;77(2):464-8
references: 22579408
references: N Engl J Med. 2012 Jun 28;366(26):2455-65
references: 22658128
references: Am J Respir Crit Care Med. 2008 Jun 15;177(12):1348-57
references: 18337594